Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. The company offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. Its products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. The company also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and diagnostics and sensors; and offers a drug delivery platform for the delivery of cannabinoid formulations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is based in Cremorne, Australia.
Show more...
CEO
Mr. Michael Johnson
국가
호주
ISIN
AU000000RNO1
상장
0 Comments
생각을 공유하기
FAQ
오늘 Rhinomed Limited 주가는 얼마인가요?▼
RNO.AU의 현재 가격은 A$0.04 AUD이며, 지난 24시간 동안 -99.89% 하락했습니다. 차트에서 Rhinomed Limited 주가 흐름을 자세히 살펴보세요.
Rhinomed Limited의 주식 심볼은 무엇인가요?▼
거래소에 따라 주식 심볼이 다를 수 있습니다. 예를 들어, 거래소에서는 Rhinomed Limited 주식이 RNO.AU 심볼로 거래됩니다.
Rhinomed Limited 주가가 오르고 있나요?▼
RNO.AU 주가는 지난주 대비 +0% 상승했고, 한 달 동안 +0% 상승했지만, 지난 1년 동안 Rhinomed Limited는 -27.03% 하락을 보였습니다.